Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences.…
Proceeds support key Phase 3 activities and U.S. expansion following FDA “Study May Proceed” and Fast Track Designation for [⁶⁸Ga]Ga-PentixaFor.
Bringing a new CAR‑T cell therapy from promising results in the lab to critically ill cancer patients is anything but straightforward. A Tagesspiegel podcast featuring, among others, Armin Rehm explores the hurdles that must be overcome along the way…
AbbVie Deutschland is supporting the further development of Nia Health’s digital, AI-supported care offering for people with atopic dermatitis. The approach ranges from documentation in patients’ everyday lives to an “AI Severity Classifier” that…
Application deadline: August 14, 2026
Silicon Valley pioneer in extrachromosomal circular DNA (Circulome) and explainable models for Biology establishes its European hub in Berlin, connecting its "Deep Biology" platform with one of Europe's leading translational research ecosystems.
Application Deadline: 16 August 2026
Application Deadline: August 2, 2026
Molecular tumor profiling and targeted therapies could enable less invasive surgery of ameloblastomas
BioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two biotech cluster organizations and DEEP - Institute for Deep Tech…
